Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 2 Expression of ACE, hHC, TGF-beta1, collagen I and III and fibronectin mRNA in patients with AS and normal or impaired LVEF. The bar graph shows ACE/GAPDH; chymase/GAPDH; TGF-beta1/PDH; collagen (Col) I/GAPDH; collagen III/GAPDH; and fibronectin (Fn)/GAPDH expression in patients with AS and normal or impaired LVEF (>55%, <55%, respectively). The ACE mRNA, hHC, TGF-beta1 and collagen I mRNA expression was significantly altered in both groups, whereas the increase in collagen III and fibronectin mRNA only reached statistical significance in patients with AS and impaired LVEF. The mean values ± SEM are presented, and analysis of variance was performed, with the Bonferroni-corrected (Tamhane-T2 procedure) p values indicated. n.s. = not significant. *p < 0.05. **p < 0.01.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement